Results 11 to 20 of about 781,661 (389)

Global Burden of Chronic Obstructive Pulmonary Disease Through 2050

JAMA Network Open, 2023
Key Points Question What will the global and regional burden of COPD be in terms of cases and prevalence by 2050? Findings In this modeling study, global COPD prevalence was projected to approach 600 million cases worldwide by 2050, which represents a ...
E. Boers, Meredith A Barrett, Jason G. Su, A. Benjafield, Sanjeev Sinha, Leanne Kaye, Heather J. Zar, V. Vuong, Daniela Téllez, R. Gondalia, Mary B. Rice, Carlos Nunez, Jadwiga A. Wedzicha, A. Malhotra   +13 more
semanticscholar   +1 more source

Barriers to adherence to home-based pulmonary rehabilitation among patients with chronic obstructive pulmonary disease in Iran: a descriptive qualitative study

BMJ Open, 2023
Objectives Chronic obstructive pulmonary disease is a chronic disease with numerous complications. Therefore, its effective management depends on home-based pulmonary rehabilitation.
Ramin Sami, Kobra Salehi, Marzieh Hashemi, Shila Haghighat, Vajihe Atashi   +4 more
doaj   +1 more source

Assessment of Risk Factors against Severity of COPD in Non-Smokers

Journal of Nepal Medical Association, 2013
Introduction: Chronic obstructive pulmonary disease in non-smokers has been an important concern in past decade. We studied the risk factors responsible for more severe Chronic obstructive pulmonary disease.
Ashok Kumar Panjwani, Shaista Ghazal, Ravi Mahat, Maria Malik, Nadeem Rizvi   +4 more
doaj   +3 more sources

Association of clonal hematopoiesis with chronic obstructive pulmonary disease

Blood, 2021
Clonal hematopoiesis of indeterminate potential (CHIP) is an age-related phenomenon that induces inflammation. Since CHIP is a risk factor for cardiovascular disease, Miller and colleagues investigated the association between CHIP and chronic obstructive
P. Miller, D. Qiao, J. Rojas-Quintero, M. Honigberg, A. Sperling, C. Gibson, A. Bick, A. Niroula, M. McConkey, Brittany Sandoval, Brian C Miller, Weiwei Shi, Kaushik Viswanathan, Matthew J. Leventhal, L. Werner, M. Moll, B. Cade, R. Barr, A. Correa, L. Cupples, Sina A. Gharib, D. Jain, S. Gogarten, L. Lange, Stephanie A. London, A. Manichaikul, G. O'Connor, E. Oelsner, S. Redline, S. Rich, J. Rotter, V. Ramachandran, B. Yu, L. Sholl, D. Neuberg, S. Jaiswal, B. Levy, C. Owen, P. Natarajan, E. Silverman, Peter van Galen, Y. Tesfaigzi, M. Cho, B. Ebert   +43 more
semanticscholar   +1 more source

Management of Chronic Obstructive Pulmonary Disease

Handbook of Healthcare in the Arab World, 2021
Chronic obstructive pulmonary disease (COPD) is a major cause of mortality and morbidity throughout the world. It is the only cause of death among the top ten causes that is increasing and is expected to become the third leading cause of death in the ...
Maher R. Khdour, Hussein O. Hallak, Hani Abdeen   +2 more
semanticscholar   +1 more source

Auditory function assessment in patients with chronic obstructive pulmonary disease

SAGE Open Medicine, 2023
Background: Chronic obstructive pulmonary disease is a multisystem disease with multiple comorbidities. Hearing is dependent on the cochlear functions that may be affected by oxygenation. Affection of hearing is problematic and represents a major concern
Hoda A Eid, Heba H Eltrawy, Shaimaa E Kabil, Hanaa A Abou-Elhassan, Rania Abdelshafy, Ahmed Aboseif, Abdullah M Albalsha, Fawzy M Omar, Mohamed Heggy, Mostafa A Ibrahim, Ashraf Moursi, Ahmed F Elbwab, Moaz Atef, Ahmed E Kabil   +13 more
doaj   +1 more source

The effect of adding inhaled corticosteroids to tiotropium and long-acting beta(2)-agonists for chronic obstructive pulmonary disease (Review) [PDF]

, 2011
BackgroundLong-acting bronchodilators comprising long-acting beta(2)-agonists and the anticholinergic agent tiotropiumare commonly used, either on their own or in combination, for managing persistent symptoms of chronic obstructive pulmonary disease ...
Aaron, Aaron, Agarwal, Akazawa, Appleton, Barr, Beeh, Berger, Briggs, Calverley, Dalal, Effing, Higgins, Hutchinson, Johnson, Kaplan, Lacasse, Meer, Najafzadeh, Najafzadeh, Nannini, Nannini Luis, Proskocil, Rodrigo, Rodrigo, Roisman, Singh, Singh, Tanaka, Tashkin, Wallukat, Welsh, Yang   +32 more
core   +1 more source

A comparison of HTLV-1 Infection Frequency in Patients with or without Tuberculosis [PDF]

Journal of Cardio-Thoracic Medicine, 2014
Introduction: To recognize the predisposing factors in tuberculosis as an endemic infection in Northeast province of Iran, this study was aimed to evaluate whether HumanT-lymphocyte type 1 (HTLV-I) as an immunosuppressive factor increases the risk of ...
Leila Ghofraniha, Elham Ghalenavi, Davood Attaran, Mohammad Towhidi, Hooshang Rafatpanah, Mohamad Khajehdaloee, Mohamad Reza Sarvghad Moghadam   +6 more
doaj   +2 more sources

Telehealthcare for chronic obstructive pulmonary disease [PDF]

, 2011
BACKGROUND: Chronic obstructive pulmonary disease (COPD) is a disease of irreversible airways obstruction in which patients often suffer exacerbations. Sometimes these exacerbations need hospital care: telehealthcare has the potential to reduce admission
Car, Josip, Liu, Joseph L. Y., McLean, Susannah, Nurmatov, Ulugbek, Pagliari, Claudia, Sheikh, Aziz   +5 more
core   +3 more sources

Global Initiative for the Diagnosis, Management, and Prevention of Chronic Obstructive Lung Disease. The 2020 GOLD Science Committee Report on COVID-19 and Chronic Obstructive Pulmonary Disease

American Journal of Respiratory and Critical Care Medicine, 2020
The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic has raised many questions about the management of patients with chronic obstructive pulmonary disease (COPD) and whether modifications of their therapy are required.
D. Halpin, G. Criner, A. Papi, Dave Singh, A. Anzueto, F. Martinez, A. Agustí, C. Vogelmeier   +7 more
semanticscholar   +1 more source